|
1
|
Cho KA, Suh JW, Lee KH, Kang JL and Woo
SY: IL-17 and IL-22 enhance skin inflammation by stimulating the
secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1
pathway. Int Immunol. 24:147–158. 2012. View Article : Google Scholar
|
|
2
|
Wang C, Wu L, Bulek K, Martin BN, Zepp JA,
Kang Z, Liu C, Herjan T, Misra S, Carman JA, et al: The
psoriasis-associated D10N variant of the adaptor Act1 with impaired
regulation by the molecular chaperone hsp90. Nat Immunol. 14:72–81.
2013. View
Article : Google Scholar
|
|
3
|
Edwards MJ, Marks R, Dykes PJ, Merrett VR,
Morgan HE and O'Donovan MR: Heat shock proteins in cultured human
keratinocytes and fibroblasts. J Invest Dermatol. 96:392–396. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilson N, McArdle A, Guerin D, Tasker H,
Wareing P, Foster CS, Jackson MJ and Rhodes LE: Hyperthermia to
normal human skin in vivo upregulates heat shock proteins 27, 60,
72i and 90. J Cutan Pathol. 27:176–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dickel H, Gambichler T, Kamphowe J,
Altmeyer P and Skrygan M: Standardized tape stripping prior to
patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNF-α
and IL-8/CXCL8 mRNA: new insights into the involvement of
'alarmins'. Contact Dermat. 63:215–222. 2010. View Article : Google Scholar
|
|
6
|
Kakeda M, Arock M, Schlapbach C and
Yawalkar N: Increased expression of heat shock protein 90 in
keratinocytes and mast cells in patients with psoriasis. J Am Acad
Dermatol. 70:683–690.e1. 2014. View Article : Google Scholar
|
|
7
|
Halevy S and Sukenik S: Different
modalities of spa therapy for skin diseases at the Dead Sea area.
Arch Dermatol. 134:1416–1420. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi YJ, Lee HJ, Lee H, Woo SY, Lee KH,
Yun ST, Kim JM, Kim HJ and Kim JW: Therapeutic effects and
immunomodulation of Suanbo mineral water therapy in a murine model
of atopic dermatitis. Ann Dermatol. 25:462–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matz H, Orion E and Wolf R: Balneotherapy
in dermatology. Dermatol Ther (Heidelb). 16:132–140. 2003.
View Article : Google Scholar
|
|
10
|
Vidal Magalhães W, Gouveia Nogueira MF and
Kaneko TM: Heat shock proteins (HSP): dermatological implications
and perspectives. Eur J Dermatol. 22:8–13. 2012.PubMed/NCBI
|
|
11
|
Zaba LC, Cardinale I, Gilleaudeau P,
Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya
I, Khatcherian A, Bluth MJ, Lowes MA and Krueger JG: Amelioration
of epidermal hyperplasia by TNF inhibition is associated with
reduced Th17 responses. J Exp Med. 204:3183–3194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyoshi S, Yamazaki S, Uchiumi A and
Katagata Y: The Hsp90 inhibitor 17-AAG represses calcium-induced
cytokeratin 1 and 10 expression in HaCaT keratinocytes. FEBS Open
Bio. 2:47–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garcia-Carbonero R, Carnero A and Paz-Ares
L: Inhibition of HSP90 molecular chaperones: moving into the
clinic. Lancet Oncol. 14:e358–e369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An WG, Schulte TW and Neckers LM: The heat
shock protein 90 antagonist geldanamycin alters chaperone
association with p210bcr-abl and v-src proteins before their
degradation by the proteasome. Cell Growth Differ. 11:355–360.
2000.PubMed/NCBI
|
|
15
|
Mimnaugh EG, Chavany C and Neckers L:
Polyubiquitination and proteasomal degradation of the p185c-erbB-2
receptor protein-tyrosine kinase induced by geldanamycin. J Biol
Chem. 271:22796–22801. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sauvageot CM, Weatherbee JL, Kesari S,
Winters SE, Barnes J, Dellagatta J, Ramakrishna NR, Stiles CD, Kung
AL, Kieran MW and Wen PY: Efficacy of the HSP90 inhibitor 17-AAG in
human glioma cell lines and tumorigenic glioma stem cells. Neuro
Oncol. 11:109–121. 2009. View Article : Google Scholar :
|
|
17
|
Nimmanapalli R, O'Bryan E and Bhalla K:
Geldanamycin and its analogue
17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and
induces apoptosis and differentiation of Bcr-Abl-positive human
leukemic blasts. Cancer Res. 61:1799–1804. 2001.PubMed/NCBI
|
|
18
|
Shimp SK III, Chafin CB, Regna NL, Hammond
SE, Read MA, Caudell DL, Rylander M and Reilly CM: Heat shock
protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr
mouse model of systemic lupus erythematosus. Cell Mol Immunol.
9:255–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chatterjee A, Dimitropoulou C,
Drakopanayiotakis F, Antonova G, Snead C, Cannon J, Venema RC and
Catravas JD: Heat shock protein 90 inhibitors prolong survival,
attenuate inflammation, and reduce lung injury in murine sepsis. Am
J Respir Crit Care Med. 176:667–675. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prakken BJ, Wendling U, van der Zee R,
Rutten VP, Kuis W and van Eden W: Induction of IL-10 and inhibition
of experimental arthritis are specific features of microbial heat
shock proteins that are absent for other evolutionarily conserved
immunodominant proteins. J Immunol. 167:4147–4153. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poulaki V, Iliaki E, Mitsiades N,
Mitsiades CS, Paulus YN, Bula DV, Gragoudas ES and Miller JW:
Inhibition of Hsp90 attenuates inflammation in endotoxin-induced
uveitis. FASEB J. 21:2113–2123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dello Russo C, Polak PE, Mercado PR,
Spagnolo A, Sharp A, Murphy P, Kamal A, Burrows FJ, Fritz LC and
Feinstein DL: The heat-shock protein 90 inhibitor
17-allylamino-17-deme-thoxygeldanamycin suppresses glial
inflammatory responses and ameliorates experimental autoimmune
encephalomyelitis. J Neurochem. 99:1351–1362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Collins CB, Aherne CM, Yeckes A, Pound K,
Eltzschig HK, Jedlicka P and de Zoeten EF: Inhibition of N-terminal
ATPase on HSP90 attenuates colitis through enhanced Treg function.
Mucosal Immunol. 6:960–971. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reinholz M, Ruzicka T and Schauber J:
Cathelicidin LL-37: an antimicrobial peptide with a role in
inflammatory skin disease. Ann Dermatol. 24:126–135. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Di Cesare A, Di Meglio P and Nestle FO:
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J
Invest Dermatol. 129:1339–1350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park CC, Kim KJ, Woo SY, Chun JH and Lee
KH: Comparison of the expression profile of JunB, c-Jun, and S100A8
(calgranulin A) in psoriasis vulgaris and guttate psoriasis. Ann
Dermatol. 21:35–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
